| Literature DB >> 34887482 |
Arthur G Fernandes1, Adriana Berezovsky1, Sung E S Watanabe1, Márcia R K H Mitsuhiro1, Marcela C Cypel1, Nívea N Ferraz1, João M Furtado1,2, Paula Y Sacai1, Sergio Muñoz3, Cristina C Cunha1,4, Galton C Vasconcelos1,5, Paulo H A Morales1, Marcos J Cohen6, Jacob M Cohen6, Mauro Campos1, Rubens Belfort1, Solange R Salomão7.
Abstract
Recently, it has been recommended that population-based studies report not only frequencies of vision impairment and blindness but also any ocular abnormalities that might lead an individual to seek for eyecare services. The current study aimed to determine prevalence of ocular findings regardless of visual acuity (VA) status in older adults from the Brazilian Amazon Region. Disturbances were grouped into: Eyelids; Anterior Segment; Posterior Segment; Increased intraocular pressure; and Overall Globe. The presence of an ocular finding was considered positive when any abnormality was noted, regardless of VA. Refractive errors were not considered. A total 2384 eligible persons were enumerated and 2041 (85.6%) examined. The prevalence of ocular disturbances in either eye was 87.0% and was associated with male gender, older age, lower education, and rural residence. Overall, main findings were pterygium, cataract, and pinguecula, occurring in 58.8%, 45.4% and 17.4%, respectively. Among individuals with 20/20 VA in both eyes, the most frequent findings were pterygium, pinguecula, and glaucoma cupping, occurring in 47.4%, 31.2% and 6.5%, respectively. The high prevalence of ocular findings observed in this population reinforces that different conditions might not immediately decrease VA but can indicate risk and/or discomfort symptoms and should be considered when planning public health ophthalmic services.Entities:
Mesh:
Year: 2021 PMID: 34887482 PMCID: PMC8660780 DOI: 10.1038/s41598-021-03172-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Enumerated and examined population by sex, age, education, and area of residence.
| Enumerated | Examined | Percent examined | |
|---|---|---|---|
| Male | 1198 (50.25) | 1000 (49.00) | 83.47 |
| Female | 1186 (49.75) | 1041 (51.00) | 87.77 |
| 45–54 | 936 (39.26) | 790 (38.71) | 84.4 |
| 55–64 | 753 (31.59) | 646 (31.65) | 85.79 |
| 65–74 | 395 (16.57) | 351 (17.20) | 88.86 |
| 75 or more | 300 (12.58) | 254 (12.44) | 84.67 |
| None | 302 (12.67) | 237 (11.61) | 78.48 |
| Less than Primary | 631 (26.47) | 546 (26.75) | 86.53 |
| Primary | 662 (27.77) | 577 (28.27) | 87.16 |
| Secondary | 345 (14.47) | 295 (14.45) | 85.51 |
| High School or higher | 444 (18.62) | 386 (18.91) | 86.94 |
| Urban | 1410 (59.14) | 1180 (57.81) | 83.69 |
| Rural | 974 (40.86) | 861 (42.19) | 88.4 |
Ocular findings per person by area of residence.
| Ocular findings | Rural area | Urban area | All |
|---|---|---|---|
| 91 (10.57) | 174 (14.75) | 265 (12.98) | |
| Blepharitis | 6 (0.70) | 40 (3.39) | 46 (2.25) |
| Structural abnormality1 | 17 (1.97) | 14 (1.19) | 31 (1.52) |
| Cornea | |||
| Cornealscar/opacification | 48 (5.57) | 68 (5.76) | 116 (5.68) |
| Keratitis | 3 (0.35) | 7 (0.59) | 10 (0.49) |
| Conjunctiva | |||
| Pterygium | 548 (63.65) | 651 (55.17) | 1199 (58.75) |
| Pinguecula | 173 (20.09) | 182 (15.42) | 355 (17.39) |
| Conjunctivitis | 6 (0.70) | 12 (1.02) | 18 (0.88) |
| Iris | |||
| Structural abnormality2 | 17 (1.97) | 27 (2.29) | 44 (2.16) |
| Absent puppilary response | 18 (2.09) | 21 (1.78) | 39 (1.91) |
| Lens | |||
| Cataract | 379 (44.02) | 547 (46.36) | 926 (45.37) |
| Pseudoexfoliation | 5 (0.58) | 12 (1.02) | 17 (0.83) |
| Glaucoma cupping | 80 (9.29) | 100 (8.47) | 180 (8.82) |
| Maculopathy3 | 40 (4.65) | 85 (7.20) | 125 (6.12) |
| Scar4 | 32 (3.72) | 40 (3.39) | 72 (3.53) |
| Age-related macular degeneration | 22 (2.56) | 20 (1.69) | 42 (2.06) |
| Vascular retinopathy | 15 (1.74) | 20 (1.69) | 35 (1.71) |
| Vitreous opacity | 17 (1.97) | 13 (1.10) | 30 (1.47) |
| Diabetic retinopathy | 9 (1.05) | 13 (1.10) | 22 (1.08) |
| Other optical atrophy | 4 (0.46) | 7 (0.59) | 11 (0.54) |
| High myopia | 2 (0.23) | 6 (0.51) | 8 (0.39) |
| Retina detachment | 1 (0.12) | 4 (0.34) | 5 (0.24) |
| Retinitis pigmentosa | 1 (0.12) | 2 (0.17) | 3 (0.15) |
| 5 (0.58) | 44 (3.73) | 49 (2.40) | |
| 8 (0.93) | 14 (1.19) | 22 (1.08) | |
| Absent/desorganized | 0 (0.00 | 1 (0.08) | 1 (0.05) |
1Entropion, irregular margins, ptosis; 2Corectopy, iris atrophy, synechiae; 3Maculopathy, drusen, retinal pigment epithelium atrophy; 4chorioretinitis, peripapilary atrophy, congenital abnormalities.
*The totals for the cause specific prevalence exceed the Total because a person can present two or more different ocular conditions in either eye.
Ocular findings in either eye according to the uncorrected visual acuity by area of residence.
| Ocular findings | Rural area | Urban area | All | ||||||
|---|---|---|---|---|---|---|---|---|---|
| UCVA 20/20 OU | UCVA ≥ 20/25 OU | UCVA ≥ 20/32 OU | UCVA 20/20 OU | UCVA ≥ 20/25 OU | UCVA ≥ 20/32 OU | UCVA 20/20 OU | UCVA ≥ 20/25 OU | UCVA ≥ 20/32 OU | |
| 18 (20.93) | 33 (20.89) | 48 (19.35) | 38 (29.46) | 61 (23.83) | 90 (25.56) | 56 (26.05) | 94 (22.70) | 138 (21.33) | |
| Blepharitis | 1 (1.16) | 1 (0.63) | 2 (0.81) | 6 (2.79) | 11 (4.30) | 16 (4.01) | 6 (2.79) | 12 (2.90) | 18 (2.78) |
| Structural abnormality1 | 0 (0.00) | 1 (0.63) | 1 (0.40) | 1 (0.78) | 1 (0.39) | 2 (0.50) | 1 (0.47) | 1 (0.24) | 3 (0.46) |
| Cornea | |||||||||
| Corneal scar/opacification | 1 (1.16) | 4 (2.53) | 6 (2.42) | 1 (0.78) | 4 (1.56) | 7 (1.75) | 2 (0.93) | 8 (1.93) | 13 (2.01) |
| Keratitis | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (0.78) | 1 (0.39) | 1 (0.25) | 1 (0.47) | 1 (0.24) | 1 (0.15) |
| Conjunctiva | |||||||||
| Pterygium | 46 (53.49) | 93 (58.86) | 145 (58.47) | 56 (43.41) | 128 (50.00) | 145 (58.47) | 102 (47.44) | 221 (53.38) | 348 (53.79) |
| Pinguecula | 32 (37.21) | 41 (25.95) | 64 (25.81) | 35 (27.13) | 65 (25.39) | 94 (23.56) | 67 (31.16) | 106 (25.60) | 158 (24.42) |
| Conjunctivitis | 0 (0.00) | 0 (0.00) | 0 (0.00) | 2 (1.55) | 2 (0.78) | 3 (0.75) | 2 (0.93) | 2 (0.48) | 3 (0.46) |
| Iris | |||||||||
| Structural abnormality2 | 0 (0.00) | 1 (0.63) | 1 (0.40) | 0 (0.00) | 1 (0.39) | 3 (0.75) | 0 (0.00) | 2 (0.48) | 4 (0.62) |
| Lens | |||||||||
| Cataract | 2 (2.33) | 11 (6.96) | 28 (11.29) | 11 (8.53) | 38 (14.84) | 84 (21.05) | 13 (6.05) | 49 (11.84) | 112 (17.31) |
| Pseudoexfoliation | 0 (0.00) | 1 (0.63) | 1 (0.40) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (0.24) | 1 (0.15) |
| Glaucoma cupping | 6 (6.98) | 13 (8.23) | 24 (9.68) | 8 (6.20) | 15 (5.86) | 22 (5.51) | 14 (6.51) | 28 (6.76) | 46 (7.11) |
| Maculopathy3 | 0 (0.00) | 1 (0.63) | 4 (1.61) | 5 (3.88) | 10 (3.91) | 18 (4.51) | 5 (2.33) | 11 (2.66) | 22 (3.40) |
| Scar4 | 3 (3.49) | 4 (2.53) | 7 (2.82) | 3 (2.33) | 9 (3.52) | 13 (3.26) | 6 (2.79) | 13 (3.14) | 20 (3.09) |
| Vascular retinopathy | 0 (0.00) | 0 (0.00) | 1 (0.40) | 4 (3.10) | 6 (2.34) | 7 (1.75) | 4 (1.86) | 6 (1.45) | 8 (1.24) |
| ARMD | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (0.78) | 1 (0.39) | 1 (0.25) | 1 (0.47) | 1 (0.24) | 1 (0.15) |
| Vitreous opacity | 0 (0.00) | 1 (0.63) | 2 (0.81) | 0 (0.00) | 1 (0.39) | 2 (0.50) | 0 (0.00) | 2 (0.48) | 4 (0.62) |
| Diabetes retinopathy | 0 (0.00) | 0 (0.00) | 2 (0.81) | 1 (0.78) | 3 (1.17) | 4 (1.00) | 1 (0.47) | 3 (0.72) | 6 (0.93) |
| Retina detachment | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (0.25) | 0 (0.00) | 0 (0.00) | 1 (0.15) |
| 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 8 (2.01) | 0 (0.00) | 0 (0.00) | 8 (1.24) | |
1Entropion irregular margins, ptosis; 2Corectopy, iris atrophy, synechiae; 3Maculopathy, drusen, retinal pigment epithelium atrophy; 4corioretinitis, peripapilary atrophy, congenital abnormalities.
*The totals for the cause specific prevalence exceed the Total because a person can present two or more different ocular conditions in either eye.